Germany · Delayed Price · Currency is EUR Stenocare Statistics
Total Valuation
Stenocare has a market cap or net worth of EUR 9.83 million. The enterprise value is 9.55 million.
| Market Cap | 9.83M |
| Enterprise Value | 9.55M |
Important Dates
The next estimated earnings date is Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 43.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +80.73% |
| Shares Change (QoQ) | -2.65% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 34.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.94 |
| PB Ratio | 33.63 |
| P/TBV Ratio | 33.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.90 |
| EV / Sales | 12.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.11.
| Current Ratio | 1.46 |
| Quick Ratio | 1.24 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.95 |
Financial Efficiency
Return on equity (ROE) is -233.84% and return on invested capital (ROIC) is -81.35%.
| Return on Equity (ROE) | -233.84% |
| Return on Assets (ROA) | -63.17% |
| Return on Invested Capital (ROIC) | -81.35% |
| Return on Capital Employed (ROCE) | -632.84% |
| Revenue Per Employee | 94,960 |
| Profits Per Employee | -411,353 |
| Employee Count | 8 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 35.72 |
Taxes
In the past 12 months, Stenocare has paid 85,916 in taxes.
| Income Tax | 85,916 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +1.89% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 46.13 |
| Average Volume (20 Days) | 71 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stenocare had revenue of EUR 759,680 and -3.29 million in losses. Loss per share was -0.10.
| Revenue | 759,680 |
| Gross Profit | -1.81M |
| Operating Income | -2.37M |
| Pretax Income | -3.20M |
| Net Income | -3.29M |
| EBITDA | -2.25M |
| EBIT | -2.37M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 604,647 in cash and 324,456 in debt, giving a net cash position of 280,191.
| Cash & Cash Equivalents | 604,647 |
| Total Debt | 324,456 |
| Net Cash | 280,191 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 292,326 |
| Book Value Per Share | 0.01 |
| Working Capital | 366,443 |
Cash Flow
| Operating Cash Flow | -453,859 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -238.06% |
| Operating Margin | -311.90% |
| Pretax Margin | -421.88% |
| Profit Margin | n/a |
| EBITDA Margin | -296.05% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Stenocare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.73% |
| Shareholder Yield | -80.73% |
| Earnings Yield | -33.47% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stenocare has an Altman Z-Score of -3.67 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.67 |
| Piotroski F-Score | 5 |